Purdue University
purdue.eduTotal trials
172
Active
19
Phase 3
0
Total enrollment
23,186
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Obesity20
- Appetitive Behavior16
- Osteoporosis8
- Overweight6
- Diabetes Mellitus, Type 25
- Specific Language Impairment5
- Language Development5
- Healthy5
Frequently asked questions about Purdue University
- How many clinical trials does Purdue University have on ClinicalTrials.gov?
- Purdue University is listed as the lead sponsor on 172 clinical trials in ClinicalTrials.gov, 19 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Purdue University's trials are in Phase 3?
- 0 of Purdue University's trials are in Phase 3.
- What therapeutic areas does Purdue University focus on?
- Purdue University's most-studied conditions on ClinicalTrials.gov are Obesity, Appetitive Behavior, Osteoporosis, Overweight, Diabetes Mellitus, Type 2.